COVID-19 breakthrough infections and pre-infection neutralizing antibody

Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, Junko S. Takeuchi, Tetsuya Mizoue, Maki Konishi, Mitsuru Ozeki, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
doi: https://doi.org/10.1101/2021.10.20.21265301

Data Availability

The data is not publicly available due to ethical restrictions and participant confidentiality concerns, but de-identified data can be available for interested researchers after permission for using the data from the National Center for Global Health and Medicine Ethics Committee.

Back to top
Posted October 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19 breakthrough infections and pre-infection neutralizing antibody
Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, Junko S. Takeuchi, Tetsuya Mizoue, Maki Konishi, Mitsuru Ozeki, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
medRxiv 2021.10.20.21265301; doi: https://doi.org/10.1101/2021.10.20.21265301
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area